Late INa Inhibition as an Antiarrhythmic Strategy
1*Lankenau Institute for Medical Research, Wynnewood, PA; and †Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA.
Insights
Targeting the late sodium channel current (late INa) offers antiarrhythmic benefits by reducing intracellular sodium and calcium, and normalizing heart repolarization. Specific late INa inhibition is most effective for arrhythmias linked to prolonged repolarization.
Area of Science:
- Cardiovascular Physiology
- Electrophysiology
- Pharmacology
Background:
- The late sodium channel current (late INa) is a recognized target for antiarrhythmic therapies.
- Its inhibition is proposed to work by suppressing calcium-mediated arrhythmias and normalizing cardiac repolarization.
Purpose of the Study:
- To elucidate the antiarrhythmic mechanisms of late INa inhibition.
- To define the conditions and limitations for specific late INa blockade.
Main Methods:
- Review and analysis of existing literature on late INa function and pharmacology.
- Examination of the interplay between late INa density, heart rate, and cardiac repolarization.
Main Results:
- Late INa inhibition can suppress intracellular calcium overload and normalize repolarization, key antiarrhythmic effects.
- Endogenous late INa is typically small, but its contribution to sodium loading is significant under specific conditions (e.g., bradycardia, prolonged repolarization).
- Specific late INa blockade is feasible at slower heart rates, but sodium channel blockers may also inhibit peak INa at rapid rates.
Conclusions:
- Specific inhibition of late INa holds promise for preventing arrhythmias associated with prolonged cardiac repolarization.
- The antiarrhythmic potential may extend to various arrhythmias characterized by elongated repolarization.
Abstract:
Late sodium channel current (late INa) is considered to be an antiarrhythmic target. The prime antiarrhythmic mechanisms of late INa inhibition have been suggested to be (1) suppression of intracellular calcium [Cai]-mediated rhythmic activity (through reduction in Cai secondary to the decrease in intracellular sodium [Nai]) and (2) normalization of repolarization. Endogenous late INa is a small current and acceleration of the heart rate decreases late INa density. Late INa influx may significantly contribute to Nai loading, but it seems to largely occur under the combined conditions of augmented late INa density, bradycardia, and prolonged repolarization. At the same time, the relative contribution of late INa (including endogenous) in any type of prolonged cardiac repolarization is critical. Sodium channel blockers inhibit both late INa and peak INa, and a specific block of late INa might be achieved at slow and normal but seems not at rapid activation rates, at which peak INa, a much greater current, is also likely to be inhibited. The antiarrhythmic potential of a specific inhibition of late INa seems to best fit for, or may be limited to, the prevention of arrhythmias associated with prolonged repolarization, but it seems to be applicable to all types of arrhythmic abnormalities with elongated cardiac repolarization.
More Related Videos
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
